glp 1 oral novo nordisk Semaglutide Approved to Reduce the Risk of Cardiovascular Events Novo Nordisk seeks approval for

Gastrointestinal (GI) side effects are common in people with diabetes treated both with metformin and with GLP-1 receptor agonists (GLP-1RAs), and they

N = 161,798 after matching GLP-1RA vs diet/exercise consultation Median follow-up: 2 years Key result: Any obesity-associated cancer HR 0.59, 95% CI 0.53-0.67 Site-specific signals: Multiple myeloma HR 0.37 Pancreatic cancer HR 0.40 Endometrial cancer HR 0.42 Colorectal cancer HR 0.49 But remember: This is observational

A-RDN induced significant increases in diuretic and natriuretic responses to GLP-1 in HF (urine flow 96.01.9 vs

In this article, learn whether weight loss patches are effective and safe.

Glucagon-like peptide-1 agonist drugs have been surging in popularity, and manufacturers are scurrying to keep up with demand

Can you donate blood on weight loss injections like Wegovy, Ozempic, or Mounjaro